Skip Ribbon Commands
Skip to main content
Menu
Veronique Viardot-Foucault

Adj Asst Prof Viardot-Foucault Veronique, Celine

DESC- Diplome d’Etudes Specialisees Complementaires, DES- Diplome d’Etudes Specialisees in Endocrinology, MD- Medical Degree, Master of Sciences

Senior Consultant

Specialty: Endocrinology, Reproductive Medicine

Sub-specialties: Assisted Reproductive Program, Andrology, Polycystic Ovarian Syndrome, Endocrinology, Adolescent Gynaecology

Conditions Treated by this Doctor:
Adolescent Gynaecology, Donor Insemination Programme, Hyperprolactinemia, Infertility, Menstrual Problems/Irregular Menses, Polycystic Ovary Syndrome, Primary and Secondary Amenorrhea, Thyroid Dysfunction.

Clinical Appointments

  • Senior Consultant Reproductive Medicine KK Women's and Children's HospitalKK Women's and Children's Hospital
  • Director, Clinical Endocrinology Reproductive Medicine KK Women's and Children's HospitalKK Women's and Children's Hospital

Profile

Dr Veronique Viardot-Foucault is a Senior Consultant, Endocrinologist and subspecialist in Reproductive Medicine at KKIVF Centre and Reproductive Medicine department of KK Women’s & Children’s Hospital in Singapore. She received her medical degree from the Medical School of Pierre et Marie Curie University in Paris. She completed a master of sciences in Reproductive Physiology in 2001. She completed her residency in endocrinology, metabolism and reproductive medicine in 2003, and was appointed Associate Consultant in the Department of Gynecology of Hotel Dieu Hospital of Paris, France for 2 years. She joined KKH since year 2008.

Her main research interests are polycystic ovarian syndrome, poor ovarian responders and ovulation assisted reproductive technique scheduling and outcomes.

Education

  • FAMS (Singapore) - 2010
  • DESC (Reproductive Medicine, France) – 2005
  • MD (Endocrinology, France) - 2003
  • Msc (Reproductive Physiology) - 2003

Professional Appointments and Committee Memberships

  • Adjunct Assistant Professor, Duke - NUS Graduate Medical School Singapore
  • Adjunct Assistant Professor, Lee Kong Chian School of Medicine
  • Senior Consultant, Department of Reproductive Medicine, KK Women’s & Children’s Hospital 2017 – Present
  • Member, American Society of Reproductive Medicine – ASRM
  • Member, Endocrine and Metabolic Society of Singapore – EMSS
  • Member, Academic Medicine Research Institute – AMRI
  • Member, European Society of Endocrinology – ESE Fellow, Academy of Medicine Singapore – AMS

Awards

  • Star Award - Singapore Health Quality Service Award 2017
  • Gold Award - Singapore Health Quality Service Award 2016
  • Silver Award - Singapore Health Quality Service Award 2015
  • Outstanding Faculty Award – Singhealth Residency 2013/2014

Research Interests

  • Assisted reproductive techniques scheduling and outcomes
  • PCOS
  • Poor ovarian responders

Publications and Research Trials

  • Age-related nomograms for antral follicle count and anti-Mullerian hormone for subfertile Chinese women in Singapore. Loy SL, Cheung YB, Fortier M, Ong CL, Tan HH, Nadarajah S, Chan JKY, Viardot-Foucault V. PLoS ONE 2017 Dec 14;12(12):e0189830
  • Kotter's Eight-Step Change Model: One Centre's Experience for Transition to the GnRH Antagonist Tan SQ, Lim WW, Liu SL, Phoon WLJ, Tan TY, Viardot-Foucault. V, Chan J, Nadarajah S and Tan HH. Protocol. J Womens Health Gynecol. 2016 June; 5(5):1-3
  • Lifestyle Behaviors in women undergoing in vitro fertilization (IVF) in Singapore: A cross sectional survey. Tan SQ, Huang EY, Lau MSK, Viardot-Foucault V, Teo S, Chan J, Tan HH, Nadarajah S. Womens Health Gynecol. 2016 Feb; 2(1);1-4
  • Estimating cumulative live-birth rates after IVF treatment with Kaplan-Meier and competing risk methods. Viardot-Foucault V, Tai BC, Chen ZJ, Lim GH, Loh SF, Tan HH, Nadarajah S, Chan JK. Eur J Obstet Gynecol Reprod Biol. 2015 Sep;192:41-6.
  • GnRH antagonist pre-treatment: one centre's experience for IVF-ICSI cycle scheduling. Viardot-Foucault V, Nadarajah S, Lye WK, Tan HH. Reprod Biomed Online. 2015 Apr;30(4):366-72. Epub 2014 Dec 24.
  • Younger women with ovulation disorders and unexplained infertility predict a higher success rate in Superovulation (SO) intrauterine insemination (IUI). Viardot-Foucault V, Tai BC, Prasath EB, Chan JKY, Loh, SF. Ann Acad Med Singapore 2014;43: 225-231.
  • Obstructed hemivagina and ipsilateral renal anomaly- a reproductive surgical unit's experience. Tan KL, Thia EW, Lau MS, Teo SB, Chan JK, Nadarajah S, Loh SF, Viardot-Foucault V, Tan HH. Ann Acad Med Singapore. 2014 May;43(5):282-4.
  • GnRH agonist trigger and ovarian hyperstimulation syndrome: relook at 'freeze-all strategy'. Ling LP, Phoon JW, Lau MS, Chan JK, Viardot-Foucault V, Tan TY, Nadarajah S, Tan HH. Reprod Biomed Online. 2014 Sep;29(3):392-4.
  • Case Report: Ovarian Sertoli Cell Tumor With Heterologous Element in a 15-year-Old Girl. Viardot- Foucault V, Kon YC, Loi SY, Lim-Tan SK, Loh SF. SJOG. 2012;43(1): 16-22.
  • The neurotensin receptor-1 pathway contributes to human ductal breast cancer progression. Dupouy S, Viardot-Foucault V, Alifano M, Souazé F, Plu-Bureau G, Chaouat M, Lavaur A, Hugol D, Gespach C, Gompel A, Forgez P. PLoS ONE. 2009;4(1):e4223. Epub 2009 Jan 19
  • Expression of neurotensin and NT1 receptor in human breast cancer: a potential role in tumor progression. Souaze F, Dupouy S, Viardot-Foucault V, Bruyneel E, Attoub S, Gespach C, Gompel A, Forgez P. Cancer Res. 2006 June 15;66(12):6243-9
  • Neurotensin receptor 1 gene activation by the Tcf/{beta}-catenin pathway is an early event in human colonic adenomas. Souaze F, Viardot-Foucault V, Roullet N, Toy-Miou-Leong M, Gompel A, Bruyneel E, Comperat E, Faux MC, Mareel M, Rostene W, Flejou JF, Gespach C, Forgez P. Carcinogenesis. 2006 April 27(4):708-716

Research Trials

  • Outcome of OI with Clomid and Letrozole for anovulatory patients, 2017 - now
  • Age related nomograms, 2015 - 2017
  • Use of DHEA in poor ovarian responders, 2011 - 2016
  • Frozen IVF Cycles types differential outcomes, 2016 - Now
  • CLBR in IVF/ICSI cycles, 2011 - 2015
  • SOIUI and GnRH antagonist, 2014 - now
  • IVF cycle scheduling with GnRH antagonist, 2012 - Now